A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non‐small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng… - Cancer …, 2014 - Wiley Online Library
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non‐
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

[PDF][PDF] A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer …, 2014 - cyberleninka.org
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

[PDF][PDF] A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer …, 2014 - academia.edu
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

[HTML][HTML] A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer …, 2014 - ncbi.nlm.nih.gov
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

[PDF][PDF] A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer …, 2014 - researchgate.net
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer …, 2014 - inis.iaea.org
[en] Preclinical studies have demonstrated that opioid receptor agonists increase the rate of
non-small cell lung cancer (NSCLC) growth and metastasis. Following institutional review …

A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non‐small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng… - Cancer …, 2014 - search.proquest.com
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non‐
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

[HTML][HTML] A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer medicine, 2014 - osti.gov
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection.

JP Cata, V Keerty, D Keerty, L Feng, PH Norman… - Cancer …, 2014 - europepmc.org
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

JP Cata, V Keerty, D Keerty, L Feng… - Cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non-
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …